Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-06-09
1999-08-10
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530300, 530350, C07K 1447, C07K 700, A61K 3804, A61K 3817
Patent
active
059359315
ABSTRACT:
The present invention provides a human apoptosis-related calcium-binding protein (HARC) and polynucleotides which identify and encode HARC. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HARC and a method for producing HARC. The invention also provides for agonists, antibodies, or antagonists specifically binding HARC, and their use, in the prevention and treatment of diseases associated with expression of HARC. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HARC for the treatment of diseases associated with the expression of HARC. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HARC.
REFERENCES:
VITO et al. Interfereing with apoptosis:Ca.sup.2 + binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271 (5248):521-525, 1996.
Goli Surya K.
Hillman Jennifer L.
Bugaisky Gabriele E.
Incyte Pharmaceuticals Inc.
Wax Robert A.
LandOfFree
Human apoptosis-related calcium-binding protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human apoptosis-related calcium-binding protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human apoptosis-related calcium-binding protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1120143